Polymorphisms of MDM4 and risk of squamous cell carcinoma of the head and neck
Authors:
- 1 July 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Pharmacogenetics and Genomics
- Vol. 21 (7) , 388-396
Abstract
Purpose Mouse double minute 4 (MDM4), a homolog of MDM2, is one of the key negative regulators of p53, and its amplification or overexpression contributes to carcinogenesis by inhibiting the p53 tumor suppressor activity. We investigated the association between MDM4 polymorphisms and the risk of squamous cell carcinoma of the head and neck (SCCHN). Methods We genotyped three MDM4 tagging polymorphisms, two in the 3′ untranslated region (rs11801299G>A and rs10900598G>T) and one in intron 1 (rs1380576C>G), in a case–control study of 1075 non-Hispanic white SCCHN patients and 1079 cancer-free controls, and evaluated their associations with SCCHN risk. Results Although none of these three polymorphisms individually had a statistically significant effect on the risk of SCCHN, nor did their combined number of putative risk genotypes (i.e. rs11801299GG, rs1380576CG+GG, and rs10900598GG) [odds ratio (OR)=1.16; 95% confidence interval (95% CI) =0.93–1.45], we found that individuals with 1–3 risk genotypes had statistically significant increased risk of oropharyngeal cancer (OR=1.32; 95% CI=1.00–1.73), particularly for those with T1–2 stage (OR=1.40; 95% CI=1.02–1.94), those with regional lymph node metastases (N1–3) (OR=1.44; 95% CI=1.07–1.95), and those with late stages (III and IV) (OR=1.34; 95% CI=1.01–1.77). Conclusion These results suggest that the joint effect of MDM4 variants may contribute to the risk of oropharyngeal cancer in non-Hispanic whites. Additional studies are warranted to unravel whether the particular stage distribution of oropharyngeal cancer with the strongest association (T1–2, N1–3, and III–IV) is a possible link with human papillomavirus-related oropharyngeal cancers.Keywords
This publication has 55 references indexed in Scilit:
- Impact of HPV in Oropharyngeal CancerJournal of Oncology, 2010
- Human Papillomavirus Seropositivity Synergizes withMDM2Variants to Increase the Risk of Oral Squamous Cell CarcinomaCancer Research, 2010
- A High-Frequency Regulatory Polymorphism in the p53 Pathway Accelerates Tumor DevelopmentCancer Cell, 2010
- Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical ImplicationsClinical Cancer Research, 2009
- Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysisBreast Cancer Research and Treatment, 2009
- MDM2 309 T/G polymorphism is associated with lung cancer risk among AsiansEuropean Journal of Cancer, 2009
- Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogeneProceedings of the National Academy of Sciences, 2009
- High levels of the p53 inhibitor MDM4 in head and neck squamous carcinomasHuman Pathology, 2007
- Haploinsufficiency of Mdm2 and Mdm4 in Tumorigenesis and DevelopmentMolecular and Cellular Biology, 2007
- Mdmx as an essential regulator of p53 activityBiochemical and Biophysical Research Communications, 2005